The risk or severity of adverse effects can be increased when thioridazine is combined with Articaine.


The risk or severity of adverse effects can be increased when brotizolam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when flumethasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when cetirizine is combined with desipramine.


The risk or severity of adverse effects can be increased when butamben is combined with butalbital.


The risk or severity of adverse effects can be increased when Halazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Halazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when clorazepate is combined with isoflurane.


The risk or severity of adverse effects can be increased when clorazepate is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when clorazepate is combined with prilocaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Difenoxin.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when cetirizine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Salsalate is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Salsalate is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when methocarbamol is combined with amoxapine.


The risk or severity of adverse effects can be increased when sertraline is combined with desipramine.


The risk or severity of adverse effects can be increased when ketorolac is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Isometheptene.


The risk or severity of adverse effects can be increased when minoxidil is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Limaprost is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Rufinamide is combined with tetracaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with mesoridazine.


The risk or severity of adverse effects can be increased when indapamide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when clenbuterol is combined with nylidrin.


The risk or severity of adverse effects can be increased when meprobamate is combined with paroxetine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when clozapine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when indomethacin is combined with Naftifine.


The risk or severity of adverse effects can be increased when prazosin is combined with Telmisartan.


The risk or severity of adverse effects can be increased when clozapine is combined with felodipine.


The risk or severity of adverse effects can be increased when prazosin is combined with methyldopa.


The risk or severity of adverse effects can be increased when nicergoline is combined with clomiphene.


The risk or severity of adverse effects can be increased when doxepin is combined with Salmeterol.


The risk or severity of adverse effects can be increased when alclofenac is combined with flumethasone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Etidocaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Spirapril.


The risk or severity of adverse effects can be increased when bromazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with clonidine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with triamterene.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Halazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Halazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when gabapentin is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Tramadol is combined with bromocriptine.


The risk or severity of adverse effects can be increased when alprazolam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when benazepril is combined with carprofen.


The risk or severity of adverse effects can be increased when Tramadol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when terconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when butamben is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with phenytoin.


The risk or severity of adverse effects can be increased when terconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when terconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when tretinoin is combined with D-mannitol.


The risk or severity of adverse effects can be increased when terconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with trazodone.


The risk or severity of adverse effects can be increased when pergolide is combined with roxithromycin.


The risk or severity of adverse effects can be increased when tolmetin is combined with flunisolide.


The risk or severity of adverse effects can be increased when pergolide is combined with etoposide.


The risk or severity of adverse effects can be increased when PRIMAQUINE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when codeine is combined with glutethimide.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when trandolapril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when butabarbital is combined with lidocaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with clemastine.


The risk or severity of adverse effects can be increased when butabarbital is combined with venlafaxine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with papaverine.


The risk or severity of adverse effects can be increased when tiagabine is combined with maprotiline.


The risk or severity of adverse effects can be increased when nicergoline is combined with lovastatin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when ketamine is combined with levodopa.


The risk or severity of adverse effects can be increased when thioridazine is combined with furosemide.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when nicergoline is combined with nelfinavir.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with atenolol.


The risk or severity of adverse effects can be increased when meprobamate is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when fenofibrate is combined with pravastatin.


The risk or severity of adverse effects can be increased when alclometasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Perospirone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when olanzapine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when HEROIN is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when scopolamine is combined with Trospium.


The risk or severity of adverse effects can be increased when midazolam is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Telmisartan is combined with benazepril.


The risk or severity of adverse effects can be increased when fenoprofen is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when butabarbital is combined with isoflurane.


The risk or severity of adverse effects can be increased when butabarbital is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when butabarbital is combined with prilocaine.


The risk or severity of adverse effects can be increased when pargyline is combined with Isometheptene.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Olopatadine.


The risk or severity of adverse effects can be increased when doxazosin is combined with furosemide.


The risk or severity of adverse effects can be increased when doxazosin is combined with tizanidine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with zaleplon.


The risk or severity of adverse effects can be increased when doxazosin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with selegiline.


The risk or severity of adverse effects can be increased when reserpine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when epirizole is combined with loteprednol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Sorafenib.


The risk or severity of adverse effects can be increased when phentolamine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Clofarabine is combined with fosinopril.


The risk or severity of adverse effects can be increased when Etidocaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when meprobamate is combined with oxymorphone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with protriptyline.


The risk or severity of adverse effects can be increased when suprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when meprobamate is combined with zopiclone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when morphine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Etidocaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Rotigotine.


The risk or severity of adverse effects can be increased when Remikiren is combined with meperidine.


The risk or severity of adverse effects can be increased when thalidomide is combined with paroxetine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with terazosin.


The risk or severity of adverse effects can be increased when sulindac is combined with Salsalate.


The risk or severity of adverse effects can be increased when Melatonin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when clonazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with diazepam.


The risk or severity of adverse effects can be increased when quazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with clindamycin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with benazepril.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when trazodone is combined with amisulpride.


The risk or severity of adverse effects can be increased when benazepril is combined with fenbufen.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with clonidine.


The risk or severity of adverse effects can be increased when propranolol is combined with bumetanide.


The risk or severity of adverse effects can be increased when trazodone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with tiapride.


The risk or severity of adverse effects can be increased when benazepril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with procarbazine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Melatonin is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Naftifine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Metipranolol.


The risk or severity of adverse effects can be increased when halcinonide is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when halcinonide is combined with memantine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when benazepril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with oxybutynin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with lomefloxacin.


The risk or severity of adverse effects can be increased when Lofexidine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with actinomycin D.


The risk or severity of adverse effects can be increased when propranolol is combined with quinapril.


The risk or severity of adverse effects can be increased when methocarbamol is combined with triprolidine.


The risk or severity of adverse effects can be increased when thiopental is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Apremilast.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when fenbufen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when reserpine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with furazolidone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Dasatinib.


The risk or severity of adverse effects can be increased when glutethimide is combined with etizolam.


The risk or severity of adverse effects can be increased when diclofenac is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Articaine.


The risk or severity of adverse effects can be increased when reserpine is combined with Melatonin.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with tolmetin.


The risk or severity of adverse effects can be increased when acebutolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when perphenazine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when perphenazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Nabilone.


The risk or severity of adverse effects can be increased when apomorphine is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when alprazolam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with thioridazine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when salicylic acid is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when glutethimide is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when dacarbazine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Treprostinil is combined with oxaprozin.


The risk or severity of adverse effects can be increased when epoprostenol is combined with sotalol.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Posaconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when pentobarbital is combined with topiramate.


The risk or severity of adverse effects can be increased when griseofulvin is combined with bepridil.


The risk or severity of adverse effects can be increased when nicergoline is combined with docetaxel.


The risk or severity of adverse effects can be increased when pirenzepine is combined with tolterodine.


The risk or severity of adverse effects can be increased when reserpine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when lorazepam is combined with ketamine.


The risk or severity of adverse effects can be increased when captopril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when lorazepam is combined with quetiapine.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with lisinopril.


The risk or severity of adverse effects can be increased when eperisone is combined with fluvastatin.


The risk or severity of adverse effects can be increased when prilocaine is combined with halothane.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with bepridil.


The risk or severity of adverse effects can be increased when Carbetocin is combined with triamterene.


The risk or severity of adverse effects can be increased when eperisone is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when amiodarone is combined with rasagiline.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when midazolam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with duloxetine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when lithium ion is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when methysergide is combined with Dasatinib.


The risk or severity of adverse effects can be increased when Butethal is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with prilocaine.


The risk or severity of adverse effects can be increased when methysergide is combined with Lapatinib.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when methadone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when isoflurane is combined with nilvadipine.


The risk or severity of adverse effects can be increased when propofol is combined with zaleplon.


The risk or severity of adverse effects can be increased when Masoprocol is combined with tenoxicam.


The risk or severity of adverse effects can be increased when levorphanol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when tizanidine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with polythiazide.


The risk or severity of adverse effects can be increased when ethanol is combined with Toloxatone.


The risk or severity of adverse effects can be increased when levorphanol is combined with prazepam.


The risk or severity of adverse effects can be increased when barnidipine is combined with Clofarabine.


The risk or severity of adverse effects can be increased when barnidipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with celiprolol.


The risk or severity of adverse effects can be increased when imipramine is combined with furosemide.


The risk or severity of adverse effects can be increased when thiamylal is combined with MELPERONE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with HEROIN.


The risk or severity of adverse effects can be increased when propoxyphene is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when pirenzepine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with zotepine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when alprazolam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when tacrolimus is combined with hydroxyurea.


The risk or severity of adverse effects can be increased when levorphanol is combined with baclofen.


The risk or severity of adverse effects can be increased when midazolam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Vilazodone.


The risk or severity of adverse effects can be increased when tiapride is combined with ethotoin.


The risk or severity of adverse effects can be increased when ketorolac is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when clidinium is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when proparacaine is combined with baclofen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with ketoprofen.


The risk or severity of adverse effects can be increased when phenytoin is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with epinephrine.


The risk or severity of adverse effects can be increased when Retigabine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when primidone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when dexamethasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when tenoxicam is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with quetiapine.


The risk or severity of adverse effects can be increased when probenecid is combined with bumetanide.


The risk or severity of adverse effects can be increased when suprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with ketamine.


The risk or severity of adverse effects can be increased when amifostine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when efavirenz is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when amifostine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when amifostine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when amifostine is combined with methazolamide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when losartan is combined with atorvastatin.


The risk or severity of adverse effects can be increased when methysergide is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when nadolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Metipranolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with reserpine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with scopolamine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when proparacaine is combined with prazepam.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with desoximetasone.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with fenbufen.


The risk or severity of adverse effects can be increased when tioconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when rasagiline is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with nimodipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Tolcapone.


The risk or severity of adverse effects can be increased when rasagiline is combined with D-mannitol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when proparacaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when rasagiline is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with tizanidine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Varenicline.


The risk or severity of adverse effects can be increased when thiopental is combined with Halazepam.


The risk or severity of adverse effects can be increased when trandolapril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when morphine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when butamben is combined with Olopatadine.


The risk or severity of adverse effects can be increased when trazodone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when morphine is combined with Etomidate.


The risk or severity of adverse effects can be increased when codeine is combined with etizolam.


The risk or severity of adverse effects can be increased when sulindac is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when oxycodone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when procaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when sulindac is combined with Droxicam.


The risk or severity of adverse effects can be increased when sulindac is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when oxycodone is combined with amobarbital.


The risk or severity of adverse effects can be increased when oxycodone is combined with Butethal.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Flibanserin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with buspirone.


The risk or severity of adverse effects can be increased when thiamylal is combined with tizanidine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with oxycodone.


The risk or severity of adverse effects can be increased when promazine is combined with gabapentin.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Butethal is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Iloperidone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with felbamate.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when trazodone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when nimodipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with formestane.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when amobarbital is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when diclofenac is combined with acemetacin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with diflorasone.


The risk or severity of adverse effects can be increased when morphine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when meprobamate is combined with imipramine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when meprobamate is combined with loratadine.


The risk or severity of adverse effects can be increased when meprobamate is combined with meperidine.


The risk or severity of adverse effects can be increased when tiapride is combined with clemastine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with trimipramine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Demecarium.


The risk or severity of adverse effects can be increased when Icatibant is combined with haloperidol.


The risk or severity of adverse effects can be increased when tiapride is combined with desipramine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when procyclidine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when pancuronium is combined with butorphanol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with quinapril.


The risk or severity of adverse effects can be increased when Normethadone is combined with potassium ion.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with bumetanide.


The risk or severity of adverse effects can be increased when Talniflumate is combined with celecoxib.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Articaine.


The risk or severity of adverse effects can be increased when Normethadone is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Perampanel is combined with sertraline.


The risk or severity of adverse effects can be increased when betamethasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when amoxapine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Pentolinium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Normethadone.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with zotepine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with HEROIN.


The risk or severity of adverse effects can be increased when glutethimide is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when HEROIN is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Torasemide.


The risk or severity of adverse effects can be increased when nadolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when mesoridazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when fenoldopam is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with nicotine.


The risk or severity of adverse effects can be increased when oxycodone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Naftifine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when clonidine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Fospropofol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with celecoxib.


The risk or severity of adverse effects can be increased when irbesartan is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when risperidone is combined with zotepine.


The risk or severity of adverse effects can be increased when levorphanol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when vindesine is combined with mitomycin C.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Etidocaine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Nebivolol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Etomidate.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with mecamylamine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when dibucaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when pimozide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when enalapril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when enalapril is combined with nifedipine.


The risk or severity of adverse effects can be increased when dibucaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with fluocinonide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when mepivacaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when butabarbital is combined with triflupromazine.


The risk or severity of adverse effects can be increased when triprolidine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when timolol is combined with propranolol.


The risk or severity of adverse effects can be increased when propofol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Nabilone is combined with spironolactone.


The risk or severity of adverse effects can be increased when buspirone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when melphalan is combined with carmustine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with antipyrine.


The risk or severity of adverse effects can be increased when diclofenac is combined with flumethasone.


The risk or severity of adverse effects can be increased when Pramocaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when zaleplon is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when oxycodone is combined with butamben.


The risk or severity of adverse effects can be increased when zaleplon is combined with prilocaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with enalapril.


The risk or severity of adverse effects can be increased when bepridil is combined with nifedipine.


The risk or severity of adverse effects can be increased when apomorphine is combined with trandolapril.


The risk or severity of adverse effects can be increased when isoflurane is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when spironolactone is combined with quinapril.


The risk or severity of adverse effects can be increased when clomipramine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when zotepine is combined with clomipramine.


The risk or severity of adverse effects can be increased when nimodipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when tetracaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when risperidone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when chloroquine is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Vilazodone is combined with sulpiride.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when amoxapine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with selegiline.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with etizolam.


The risk or severity of adverse effects can be increased when olanzapine is combined with protriptyline.


The risk or severity of adverse effects can be increased when norepinephrine is combined with metaraminol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when olanzapine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Asenapine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Naftifine is combined with Droxicam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with tiapride.


The risk or severity of adverse effects can be increased when Metixene is combined with topiramate.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when trazodone is combined with proparacaine.


The risk or severity of adverse effects can be increased when trazodone is combined with Halazepam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with hydralazine.


The risk or severity of adverse effects can be increased when protriptyline is combined with felbamate.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when dipyridamole is combined with quetiapine.


The risk or severity of adverse effects can be increased when methazolamide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Rosuvastatin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when alprazolam is combined with loratadine.


The risk or severity of adverse effects can be increased when promazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when ondansetron is combined with cetirizine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Icatibant.


The risk or severity of adverse effects can be increased when azelastine is combined with equilin.


The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when morniflumate is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when metoprolol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when midazolam is combined with tiapride.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with levodopa.


The risk or severity of adverse effects can be increased when pergolide is combined with Pazopanib.


The risk or severity of adverse effects can be increased when flunarizine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with medrysone.


The risk or severity of adverse effects can be increased when zotepine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when loxapine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Nepafenac.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with pirenzepine.


The risk or severity of adverse effects can be increased when oxazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with ambenonium.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with clidinium.


The risk or severity of adverse effects can be increased when PENTAERYTHRITOL TETRANITRATE is combined with Nintedanib.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with flunisolide.


The risk or severity of adverse effects can be increased when indomethacin is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Limaprost is combined with 3,4-Dihydroxybenzaldehyde.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when haloperidol is combined with pentazocine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with oxprenolol.


The risk or severity of adverse effects can be increased when valsartan is combined with resveratrol.


The risk or severity of adverse effects can be increased when raloxifene is combined with Ospemifene.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with prazepam.


The risk or severity of adverse effects can be increased when moclobemide is combined with bromocriptine.


The risk or severity of adverse effects can be increased when apomorphine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when dantrolene is combined with Milnacipran.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with etizolam.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Retigabine.


The risk or severity of adverse effects can be increased when zotepine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Normethadone is combined with loratadine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when apomorphine is combined with quinapril.


The risk or severity of adverse effects can be increased when pergolide is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Ephedrine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when apomorphine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when thioridazine is combined with levorphanol.


The risk or severity of adverse effects can be increased when pentazocine is combined with doxepin.


The risk or severity of adverse effects can be increased when zopiclone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when risperidone is combined with flunarizine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Agomelatine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when pergolide is combined with vinblastine.


The risk or severity of adverse effects can be increased when flurazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when suprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when promazine is combined with tiapride.


The risk or severity of adverse effects can be increased when sulpiride is combined with amoxapine.


The risk or severity of adverse effects can be increased when indapamide is combined with Bretylium.


The risk or severity of adverse effects can be increased when sulpiride is combined with nortriptyline.


The risk or severity of adverse effects can be increased when sulindac is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Carbetocin is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when diflorasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when codeine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when codeine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Butoconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with baclofen.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with felbamate.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with azelastine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Perospirone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with clonidine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with lisinopril.


The risk or severity of adverse effects can be increased when Lacidipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when chloroquine is combined with flumethasone.


The risk or severity of adverse effects can be increased when acemetacin is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when selegiline is combined with Salbutamol.


The risk or severity of adverse effects can be increased when Echothiophate is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when midazolam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when temazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when irbesartan is combined with nadolol.


The risk or severity of adverse effects can be increased when tinidazole is combined with ethanol.


The risk or severity of adverse effects can be increased when clorazepate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when amiodarone is combined with bumetanide.


The risk or severity of adverse effects can be increased when hydralazine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when triazolam is combined with ethotoin.


The risk or severity of adverse effects can be increased when triazolam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when amiodarone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when amiodarone is combined with quinapril.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Suvorexant is combined with citalopram.


The risk or severity of adverse effects can be increased when codeine is combined with Normethadone.


The risk or severity of adverse effects can be increased when rizatriptan is combined with pimozide.


The risk or severity of adverse effects can be increased when clozapine is combined with reserpine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with memantine.


The risk or severity of adverse effects can be increased when fluocinonide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when biperiden is combined with butorphanol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Lapatinib.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when fluocinonide is combined with ambenonium.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Riociguat.


The risk or severity of adverse effects can be increased when alprostadil is combined with salicylic acid.


The risk or severity of adverse effects can be increased when codeine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when buspirone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when amiodarone is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when ATROPINE is combined with biperiden.


The risk or severity of adverse effects can be increased when methysergide is combined with Salbutamol.


The risk or severity of adverse effects can be increased when mecamylamine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when isoflurane is combined with butamben.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Tramadol is combined with meprobamate.


The risk or severity of adverse effects can be increased when quinapril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when GLYCEROL PHENYLBUTYRATE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when amisulpride is combined with tizanidine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with trimipramine.


The risk or severity of adverse effects can be increased when chloroquine is combined with budesonide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with procaine.


The risk or severity of adverse effects can be increased when celecoxib is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when ropinirole is combined with lisinopril.


The risk or severity of adverse effects can be increased when betamethasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when butenafine is combined with barnidipine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when lidocaine is combined with tiapride.


The risk or severity of adverse effects can be increased when Tavaborole is combined with eperisone.


The risk or severity of adverse effects can be increased when proparacaine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Sacubitril is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Eprosartan is combined with rescinnamine.


The risk or severity of adverse effects can be increased when oxycodone is combined with felbamate.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when flurazepam is combined with estazolam.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with butamben.


The risk or severity of adverse effects can be increased when flurazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when loxapine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with moclobemide.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with lidocaine.


The risk or severity of adverse effects can be increased when selegiline is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when amisulpride is combined with cetirizine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with clomipramine.


The risk or severity of adverse effects can be increased when amisulpride is combined with protriptyline.


The risk or severity of adverse effects can be increased when gabapentin is combined with ondansetron.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with Tapentadol.


The risk or severity of adverse effects can be increased when tolterodine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when perphenazine is combined with dibucaine.


The risk or severity of adverse effects can be increased when ramipril is combined with triamterene.


The risk or severity of adverse effects can be increased when dyclonine is combined with cetirizine.


The risk or severity of adverse effects can be increased when brotizolam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Butethal is combined with Retigabine.


The risk or severity of adverse effects can be increased when dyclonine is combined with protriptyline.


The risk or severity of adverse effects can be increased when reserpine is combined with isoflurane.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when reserpine is combined with prilocaine.


The risk or severity of adverse effects can be increased when reserpine is combined with ethotoin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when pentobarbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when gabapentin is combined with zonisamide.


The risk or severity of adverse effects can be increased when thiothixene is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Tapentadol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with valsartan.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with prilocaine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with meperidine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with ethotoin.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with ramipril.


The risk or severity of adverse effects can be increased when apomorphine is combined with rasagiline.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with alclofenac.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when epoprostenol is combined with dipyridamole.


The risk or severity of adverse effects can be increased when bromazepam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Apremilast is combined with diflorasone.


The risk or severity of adverse effects can be increased when alclofenac is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when bromazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when alclofenac is combined with formestane.


The risk or severity of adverse effects can be increased when Lofexidine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Rotigotine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with malathion.


The risk or severity of adverse effects can be increased when antipyrine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with tretinoin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with isoflurane.


The risk or severity of adverse effects can be increased when halothane is combined with carisoprodol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when halothane is combined with nimodipine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when etodolac is combined with Clobetasone.


The risk or severity of adverse effects can be increased when venlafaxine is combined with procarbazine.


The risk or severity of adverse effects can be increased when Limaprost is combined with Apixaban.


The risk or severity of adverse effects can be increased when methysergide is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when olanzapine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when butabarbital is combined with secobarbital.


The risk or severity of adverse effects can be increased when estazolam is combined with glutethimide.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Desloratadine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with mepivacaine.


The risk or severity of adverse effects can be increased when prazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when triazolam is combined with zotepine.


The risk or severity of adverse effects can be increased when celecoxib is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when furazolidone is combined with Arformoterol.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when metaraminol is combined with nylidrin.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when benazepril is combined with Bretylium.


The risk or severity of adverse effects can be increased when Treprostinil is combined with floctafenine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when oxazepam is combined with zaleplon.


The risk or severity of adverse effects can be increased when oxazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when doxepin is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when azelastine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with cilazapril.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when cerulenin is combined with gabapentin.


The risk or severity of adverse effects can be increased when estrone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when celecoxib is combined with prednisone.


The risk or severity of adverse effects can be increased when tiagabine is combined with citalopram.


The risk or severity of adverse effects can be increased when clorazepate is combined with amoxapine.


The risk or severity of adverse effects can be increased when clorazepate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when tacrolimus is combined with glimepiride.


The risk or severity of adverse effects can be increased when oxazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when enflurane is combined with thiopental.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when ATROPINE is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Quinine.


The risk or severity of adverse effects can be increased when itraconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when enflurane is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with etizolam.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nifedipine.


The risk or severity of adverse effects can be increased when cabergoline is combined with mequitazine.


The risk or severity of adverse effects can be increased when celecoxib is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when quinapril is combined with bumetanide.


The risk or severity of adverse effects can be increased when rescinnamine is combined with chloroquine.


The risk or severity of adverse effects can be increased when Icatibant is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when rescinnamine is combined with sulindac.


The risk or severity of adverse effects can be increased when metoclopramide is combined with triflupromazine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with sotalol.


The risk or severity of adverse effects can be increased when baclofen is combined with clonazepam.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with celecoxib.


The risk or severity of adverse effects can be increased when alclofenac is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when zopiclone is combined with zotepine.


The risk or severity of adverse effects can be increased when zopiclone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when ketamine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when lithium ion is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ropinirole is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when venlafaxine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Articaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with pentazocine.


The risk or severity of adverse effects can be increased when halothane is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Droxicam is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with niflumic acid.


The risk or severity of adverse effects can be increased when tolmetin is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ramipril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Ramelteon.


The risk or severity of adverse effects can be increased when morphine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with thioridazine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with losartan.


The risk or severity of adverse effects can be increased when Darunavir is combined with oxycodone.


The risk or severity of adverse effects can be increased when tolmetin is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when linezolid is combined with loxapine.


The risk or severity of adverse effects can be increased when linezolid is combined with Remoxipride.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when cefotetan is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when codeine is combined with spironolactone.


The risk or severity of adverse effects can be increased when meprobamate is combined with tizanidine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when meprobamate is combined with flurazepam.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with spironolactone.


The risk or severity of adverse effects can be increased when benzocaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when cabergoline is combined with tamoxifen.


The risk or severity of adverse effects can be increased when rizatriptan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Asenapine.


The risk or severity of adverse effects can be increased when cabergoline is combined with thioridazine.


The risk or severity of adverse effects can be increased when butenafine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when topiramate is combined with protriptyline.


The risk or severity of adverse effects can be increased when topiramate is combined with cetirizine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with enalapril.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with betamethasone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when duloxetine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when butorphanol is combined with zopiclone.


The risk or severity of adverse effects can be increased when levorphanol is combined with amisulpride.


The risk or severity of adverse effects can be increased when Olsalazine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when scopolamine is combined with tiagabine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Normethadone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with budesonide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with butamben.


The risk or severity of adverse effects can be increased when codeine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when thiothixene is combined with topiramate.


The risk or severity of adverse effects can be increased when Remoxipride is combined with efavirenz.


The risk or severity of adverse effects can be increased when Sitaxsentan is combined with atorvastatin.


The risk or severity of adverse effects can be increased when benazepril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when indomethacin is combined with haloperidol.


The risk or severity of adverse effects can be increased when indomethacin is combined with tolmetin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when proparacaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with trandolapril.


The risk or severity of adverse effects can be increased when zopiclone is combined with imipramine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Droxicam.


The risk or severity of adverse effects can be increased when risperidone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when tetracaine is combined with clonidine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with oxaprozin.


The risk or severity of adverse effects can be increased when zopiclone is combined with loratadine.


The risk or severity of adverse effects can be increased when 5-Fluorouracil is combined with leflunomide.


The risk or severity of adverse effects can be increased when docetaxel is combined with tamoxifen.


The risk or severity of adverse effects can be increased when trazodone is combined with Perospirone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with primidone.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when etizolam is combined with zotepine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with estazolam.


The risk or severity of adverse effects can be increased when antipyrine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when methadone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when methadone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ramipril is combined with nicardipine.


The risk or severity of adverse effects can be increased when lorazepam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when reserpine is combined with terazosin.


The risk or severity of adverse effects can be increased when reserpine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when lidocaine is combined with butamben.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when tirofiban is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when fenoldopam is combined with morphine.


The risk or severity of adverse effects can be increased when secobarbital is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when alclofenac is combined with Deferasirox.


The risk or severity of adverse effects can be increased when olanzapine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when lithium ion is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Paliperidone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when benzoic acid is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Paliperidone is combined with tiagabine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with cocaine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with ondansetron.


The risk or severity of adverse effects can be increased when Paliperidone is combined with zonisamide.


The risk or severity of adverse effects can be increased when nisoldipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when levodopa is combined with procarbazine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Pizotifen.


The risk or severity of adverse effects can be increased when reserpine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Retigabine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Pregabalin is combined with citalopram.


The risk or severity of adverse effects can be increased when Naftifine is combined with Mometasone.


The risk or severity of adverse effects can be increased when procarbazine is combined with oxycodone.


The risk or severity of adverse effects can be increased when procarbazine is combined with buspirone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when cetirizine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when thioridazine is combined with procaine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when methadone is combined with zopiclone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with brimonidine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Nabilone.


The risk or severity of adverse effects can be increased when phenytoin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with alclofenac.


The risk or severity of adverse effects can be increased when Carbetocin is combined with sotalol.


The risk or severity of adverse effects can be increased when oxaprozin is combined with fenbufen.


The risk or severity of adverse effects can be increased when bupivacaine is combined with butamben.


The risk or severity of adverse effects can be increased when imipramine is combined with clonazepam.


The risk or severity of adverse effects can be increased when cilnidipine is combined with metoprolol.


The risk or severity of adverse effects can be increased when indomethacin is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Naftifine is combined with formestane.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Olmesartan is combined with lisinopril.


The risk or severity of adverse effects can be increased when cilnidipine is combined with ropinirole.


The risk or severity of adverse effects can be increased when nortriptyline is combined with dobutamine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with loratadine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nitrendipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with CAPECITABINE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with procaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with imipramine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with ACENOCOUMAROL.


The risk or severity of adverse effects can be increased when methysergide is combined with histamine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Articaine.


The risk or severity of adverse effects can be increased when Naftifine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when sulfamethoxazole is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Olopatadine is combined with doxepin.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when butorphanol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when biperiden is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when L-tryptophan is combined with pargyline.


The risk or severity of adverse effects can be increased when methadone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with dobutamine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with zotepine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when methysergide is combined with alprazolam.


The risk or severity of adverse effects can be increased when methysergide is combined with nisoldipine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with prazepam.


The risk or severity of adverse effects can be increased when THYMOL is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when aspirin is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Naftifine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when lorazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when levorphanol is combined with clonidine.


The risk or severity of adverse effects can be increased when lorazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when etoposide is combined with clozapine.


The risk or severity of adverse effects can be increased when metaproterenol is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when metaproterenol is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Propiverine is combined with Metixene.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with antipyrine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when methylphenidate is combined with bromocriptine.


The risk or severity of adverse effects can be increased when haloperidol is combined with clidinium.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with fluocinonide.


The risk or severity of adverse effects can be increased when carisoprodol is combined with scopolamine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when prazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when midazolam is combined with clomipramine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with betamethasone.